Evidence map›Paper›PMID 37704779›Full record

ArticleEuropean journal of human genetics : EJHG2023

Börjeson-Forssman-Lehmann syndrome: delineating the clinical and allelic spectrum in 14 new families.

Vani Jain, Seow Hoong Foo, Stephen Chooi, Celia Moss, Richard Goodwin, Siren Berland, Angus J Clarke, Sally J Davies, Sian Corrin, Oliver Murch and 15 more

Open access · hybridAbstract read
In one paragraph

Article in European journal of human genetics : EJHG, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.6field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Ambivalence and regret in genome sequencing.European journal of human genetics : EJHG · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors at 15 institutions in 6 countries.

Vani Jain *All Wales Medical Genomics Service, University Hospital of Wales, Heath Park, Cardiff, CF14 4XW, UK. vani.jain@wales.nhs.uk.ORCID 0000-0002-8516-8261
Seow Hoong FooDepartment of Dermatology, Birmingham Women's and Children's NHS Foundation Trust, Birmingham, B4 6NH, UK.
Stephen ChooiSchool of Medicine, Cardiff University, Heath Park Campus, Cardiff, CF14 4YS, UK.
Celia MossDepartment of Dermatology, Birmingham Women's and Children's NHS Foundation Trust, Birmingham, B4 6NH, UK.
Richard GoodwinDepartment of Dermatology, Royal Gwent Hospital, Newport, NP20 2UB, UK.
Siren BerlandDepartment of Medical Genetics, Haukeland University Hospital, 5021, Bergen, Norway.ORCID 0000-0002-8048-6682
Angus J ClarkeAll Wales Medical Genomics Service, University Hospital of Wales, Heath Park, Cardiff, CF14 4XW, UK.ORCID 0000-0002-1200-9286
Sally J DaviesAll Wales Medical Genomics Service, University Hospital of Wales, Heath Park, Cardiff, CF14 4XW, UK.
Sian CorrinAll Wales Medical Genomics Service, University Hospital of Wales, Heath Park, Cardiff, CF14 4XW, UK.ORCID 0000-0001-5463-0903
Oliver MurchAll Wales Medical Genomics Service, University Hospital of Wales, Heath Park, Cardiff, CF14 4XW, UK.ORCID 0000-0003-1298-5647
Samantha DoyleDepartment of Medical Genetics, Our Lady's Children's Hospital, Crumlin, Dublin, D12 N512, Ireland.
Gail E GrahamDepartment of Genetics, Children's Hospital of Eastern Ontario, Ottawa, Ontario, K1H 8L1, Canada.
Lynn GreenhalghLiverpool Centre for Genomic Medicine, Liverpool Women's Hospital, Liverpool, L8 7SS, UK.
Susan E HolderNorth West Thames Regional Genetic Service, Kennedy Galton Centre, Northwick Park Hospital, Harrow, HA1 3UJ, UK.
Diana JohnsonDepartment of Clinical Genetics, Northern General Hospital, Sheffield, S5 7AU, UK.
Ajith KumarNorth East Thames Regional Genetics Service, Great Ormond Street Hospital, London, WC1N 3JH, UK.ORCID 0000-0003-3878-2856
Roger L LaddaDepartment of Pediatrics, Division of Human Genetics, Penn State Health Children's Hospital, Hershey, Pennsylvania, 17033, USA.
Susan SellDepartment of Pediatrics, Division of Human Genetics, Penn State Health Children's Hospital, Hershey, Pennsylvania, 17033, USA.
Amber BegtrupGeneDx, Gaithersburg, Maryland, 20877, USA.ORCID 0000-0002-2872-3281
Sally A LynchDepartment of Medical Genetics, Our Lady's Children's Hospital, Crumlin, Dublin, D12 N512, Ireland.
Emma McCannLiverpool Centre for Genomic Medicine, Liverpool Women's Hospital, Liverpool, L8 7SS, UK.
Rune ØsternDepartment of Medical Genetics, St. Olavs Hospital, Trondheim University Hospital, 7030, Trondheim, Norway.
Caroline PottingerAll Wales Medical Genomics Service, University Hospital of Wales, Heath Park, Cardiff, CF14 4XW, UK.
Miranda SplittNorthern Genetics Service, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, NE1 3BZ, UK.
Andrew E Fry *All Wales Medical Genomics Service, University Hospital of Wales, Heath Park, Cardiff, CF14 4XW, UK. fryae@cardiff.ac.uk.ORCID 0000-0001-9778-6924
University Hospital of Wales · GBChildren's Health Ireland at Crumlin · IEPenn State Milton S. Hershey Medical Center · USUniversity of Liverpool · GBBirmingham Women’s and Children’s NHS Foundation Trust · GBCardiff University · GBChildren's Hospital of Eastern Ontario · CAGleneagles Hospital · SGGreat Ormond Street Hospital · GBHaukeland University Hospital · NONewcastle upon Tyne Hospitals NHS Foundation Trust · GBNorthern General Hospital · GBNorthwick Park Hospital · GBRoyal Gwent Hospital · GBSt Olav's University Hospital · NO

Funding

Wellcome Trust
6 · The paper itself

Abstract

Börjeson-Forssman-Lehmann syndrome (BFLS) is an X-linked intellectual disability syndrome caused by variants in the PHF6 gene. We ascertained 19 individuals from 15 families with likely pathogenic or pathogenic PHF6 variants (11 males and 8 females). One family had previously been reported. Six variants were novel. We analysed the clinical and genetic findings in our series and compared them with reported BFLS patients. Affected males had classic features of BFLS including intellectual disability, distinctive facies, large ears, gynaecomastia, hypogonadism and truncal obesity. Carrier female relatives of affected males were unaffected or had only mild symptoms. The phenotype of affected females with de novo variants overlapped with the males but included linear skin hyperpigmentation and a higher frequency of dental, retinal and cortical brain anomalies. Complications observed in our series included keloid scarring, digital fibromas, absent vaginal orifice, neuropathy, umbilical hernias, and talipes. Our analysis highlighted sex-specific differences in PHF6 variant types and locations. Affected males often have missense variants or small in-frame deletions while affected females tend to have truncating variants or large deletions/duplications. Missense variants were found in a minority of affected females and clustered in the highly constrained PHD2 domain of PHF6. We propose recommendations for the evaluation and management of BFLS patients. These results further delineate and extend the genetic and phenotypic spectrum of BFLS.

Indexed as

HypogonadismIntellectual DisabilityX-Linked Intellectual DisabilityEpilepsyFaceFemaleFingersGrowth DisordersHumansMaleObesity

Identifiers

PMID37704779
PMCPMC10689765
OpenAlexW4386697219

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.